Compound pharmaceutical composition and processes for treating diseases related to unregulated tyrosine kinase signal transduction and for regulating tyrosine kinase signal transduction

摘要

The present invention relates to compounds of the formulae CHEM wherein X is Br, Cl, F or I; CHEM wherein Z is Br, Cl, F, I, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl or tert-butyl; capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.